The Avicenna Alliance

  • A global organization that brings together health care stakeholders
  • With the goal of making in silico medicine standard practice in health care
  • Through a collaborative ecosystem of patients, clinicians, academics, industries, policy makers, regulators & payers

 

Our Mission

Significantly accelerate medical innovation and its practical implementation, to ensure safe, affordable and cost effective health care through the large scale adoption of in silico medicine (Computer Modeling & Simulation, CM&S)

 

Avicenna Leaflet

For a concise overview of the purpose of the Avicenna Alliance, its work and long-term vision and a summary of what in silico means for and the Alliance's purpose, please download the Avicenna Alliance Flyer.

The Avicenna Leaflet

Downloadable version (1,7 MB)

Avicenna Journey

Have a look at the Avicenna Alliance journey so far. Please note this document is an interactive timeline, after downloading move your mouse over various events and photos will appear.

The Avicenna Journey

Downloadable version (2,0 MB)

Avicenna Alliance news

Dassault to enhance clinical tech with Medidata acquisition

Dassault Systèmes acquired Medidata, major player in information technologies for clinical trials, for $5.5 billion. This represents to...

find out more ›

Promote adoption of In Silico Trials through EMA’s strategy on Regulatory Science to 2025

The European Medicine Agency (EMA) has recently published a document that describes its strategy until 2025....

find out more ›

European Strategy for High Performance Computing

On the 17 June, the European Commission published a presentation explaining why they indicated High Performance Computing (HPC) as a priority area for...

find out more ›

Show all activites